title: Epirubicin plus ifosfamide and dacarbazine (EID) in advanced soft tissue sarcomas.
authors.affiliation: Division of Medical Oncology, Istituto Nazionale Tumori, Milano, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Casali
authors.forename: U
authors.initials: U
authors.lastname: Pastorino
authors.forename: P
authors.initials: P
authors.lastname: Zucchinelli
authors.forename: L
authors.initials: L
authors.lastname: Devizzi
authors.forename: A
authors.initials: A
authors.lastname: Azzarelli
authors.forename: V
authors.initials: V
authors.lastname: Quagliuolo
authors.forename: P
authors.initials: P
authors.lastname: Bignami
authors.forename: A
authors.initials: A
authors.lastname: Santoro
authors.forename: G
authors.initials: G
authors.lastname: Bonadonna
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D003606:Dacarbazine / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D012509:Sarcoma / Q000188:drug therapy*; D012983:Soft Tissue Neoplasms / Q000188:drug therapy*
chemical_list: D015251:Epirubicin; D003606:Dacarbazine; D007069:Ifosfamide